Resistance Training for Individuals With Mild Cognitive Impairment (TRAIN4BRAIN)

December 28, 2023 updated by: Nuno Miguel Pintassilgo da Silva Fonseca, University of Beira Interior

Effects of Different Resistance Training Volumes on Cognitive Function, Oxidative Stress, Immunological Response, Lipid Profile, Glycemic Status, Liver Function, Muscle Function, Hemodynamic Response, and Physical Performance in Individuals With Mild Cognitive Impairment

This research project aims to analyze the effects of different resistance training volumes on cognitive function, oxidative stress, immunological response, lipid profile, glycemic status, liver function, muscle function, hemodynamic response, and physical performance in individuals with mild cognitive impairment. First the investigators will analyze the effects of a single resistance training session (acute effects) with one and three sets on hemodynamic and physical performance in individuals with mild cognitive impairment. After, the investigators will analyze the effects of an 8-week resistance training program with one or three sets on cognitive function, oxidative stress, immunological response, lipid profile, glycemic status, liver function, muscle function, hemodynamic response, and physical performance in individuals with mild cognitive impairment. The investigators hypothesize that a single resistance training session of one or three sets will increase the acute hemodynamic and physical performance stress in individuals with mild cognitive impairment, although with a higher magnitude in the session with three sets. Furthermore, we hypothesize that eight weeks of resistance training with one or three sets will induce similar improvements in cognitive function, oxidative stress, immunological response, lipid profile, glycemic status, liver function, muscle function, hemodynamic response, and physical performance in individuals with mild cognitive impairment.

Study Overview

Detailed Description

Following specific inclusion and exclusion criteria (see Eligibility Criteria), participants will be recruited from residential care facilities or day centers. For the acute effects study (cross-over study), participants will randomly perform two resistance training sessions separated by one week of rest: i) one session with one set and ii) another session of three sets. The intensity of the exercises, number of repetitions, type and order of exercises, movement velocity, and rest time between exercises will be the same in both groups. Before, immediately after, and 72 hours after the sessions, a battery of tests will be applied to evaluate the changes in blood pressure, heart rate, tympanic temperature, medicine ball throw distance, five-repetition sit-to-stand time, and handgrip strength. Afterward, participants will be randomly assigned into a one-set or three-set group to perform an eight-week resistance training intervention. As for the acute effects study, the prescription of the other acute training variables will be the same for both groups. A control group (without any form of physical exercise), recruited at the beginning of the research project, will also be part of the study. Before and after the intervention, a battery of tests will be applied to determine the training program's impact on cognitive function, oxidative stress, immunological response, lipid profile, glycemic status, liver function, muscle function, hemodynamic response, and physical performance in individuals with mild cognitive impairment.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Covilhã, Portugal
        • Recruiting
        • University of Beira Interior
        • Contact:
          • Nuno Fonseca

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria:

  • Clinical diagnosis of mild cognitive impairment
  • SPPB score ≥ 3 points
  • Willingness to participate in the interventions and collaborate with the research team
  • Must be able to provide informed consent (oral or written)

Exclusion criteria:

  • Severe dementia
  • Severe comorbidity that negatively influences participation in the intervention
  • Color blindness
  • Fractures in the last three months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: One Resistance Training Set (Single Session)
The participants will perform one resistance training session with one set.
The participants will perform a resistance training session with one set per exercise. The training sequence will be the following: i) 10 minutes of warm-up walking on the treadmill at 50% of maximal walking velocity, ii) 1 set of 10 repetitions at 60% of one-repetition maximum (1RM) in the leg press, iii) 1 set of 10 repetitions at 55% 1RM in the chest press, iv) 1 set of 10 repetitions in the sit-to-stand exercise, v) 1 set of 10 repetitions in the 1-kg medicine ball throw exercise, and vi) 5 minutes walking on the treadmill at 60% of maximal walking velocity.
Experimental: Three Resistance Training Sets (Single Session)
The participants will perform one resistance training session with three sets.
The participants will perform a resistance training session with three sets per exercise. The training sequence will be the following: i) 10 minutes of warm-up walking on the treadmill at 50% of maximal walking velocity, ii) 3 sets of 10 repetitions at 60% of one-repetition maximum (1RM) in the leg press, iii) 3 sets of 10 repetitions at 55% 1RM in the chest press, iv) 3 sets of 10 repetitions in the sit-to-stand exercise, v) 3 sets of 10 repetitions in the 1-kg medicine ball throw exercise, and vi) 5 minutes walking on the treadmill at 60% of maximal walking velocity.
Experimental: One Resistance Training Set (8 Weeks)
The participants will perform eight weeks of resistance training (two sessions per week, separated by 72 hours of rest) with one set.
The participants will perform eight weeks of resistance training with one set per exercise. The training sequence will be the following: i) 10 minutes of warm-up walking on the treadmill at 50% of maximal walking velocity, ii) 1 set of 10 repetitions between 50-70% of one-repetition maximum (1RM) in the leg press, iii) 1 set of 10 repetitions between 40-60% 1RM in the chest press, iv) 1 set of 6-12 repetitions in the sit-to-stand exercise, v) 1 set of 6-12 repetitions in the 1-kg medicine ball throw exercise, and vi) 5 minutes walking on the treadmill at 60% of maximal walking velocity.
Experimental: Three Resistance Training Sets (8 Weeks)
The participants will perform eight weeks of resistance training (two sessions per week, separated by 72 hours of rest) with three sets.
The participants will perform eight weeks of resistance training with three sets per exercise. The training sequence will be the following: i) 10 minutes of warm-up walking on the treadmill at 50% of maximal walking velocity, ii) 3 sets of 10 repetitions between 50-70% of one-repetition maximum (1RM) in the leg press, iii) 3 sets of 10 repetitions between 40-60% 1RM in the chest press, iv) 3 sets of 6-12 repetitions in the sit-to-stand exercise, v) 3 sets of 6-12 repetitions in the 1-kg medicine ball throw exercise, and vi) 5 minutes walking on the treadmill at 60% of maximal walking velocity.
Experimental: Control (8 Weeks)
The participants will not perform any form of physical exercise during the intervention period of eight weeks.
The participants in the control group will maintain their regular daily activities without performing any form of physical exercise.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Systolic blood pressure (SBP)
Time Frame: Change from baseline to 0 minutes and 72 hours after the sessions
In the cross-over study (acute effects), the SBP will be assessed through a blood pressure device.
Change from baseline to 0 minutes and 72 hours after the sessions
Handgrip strength (HGS)
Time Frame: Change from baseline to 0 minutes and 72 hours after the sessions
In the cross-over study (acute effects), the HGS will be assessed through an analogic dynamometer.
Change from baseline to 0 minutes and 72 hours after the sessions
Dementia Rating Scale-2 (DRS-2)
Time Frame: Change from baseline to week 8
In the eight-week study, the DRS-2 questionnaire will be applied to analyze the overall level of cognitive function through five subscales: attention, initiation/perseveration, construction, conceptualization, and memory.
Change from baseline to week 8
Brain-Derived Neurotrophic Factor (BDNF)
Time Frame: Change from baseline to week 8
In the eight-week study, the BDNF protein levels will be analyzed through specific blood testing kits.
Change from baseline to week 8
Short Physical Performance Battery (SPPB)
Time Frame: Change from baseline until week 8
In the eight-week study, the SPPB will determine the overall level of functional performance through three tests: balance (feet side by side, semi tandem, tandem), 4-meter walking, and 5-repetition sit-to-stand.
Change from baseline until week 8

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diastolic blood pressure (DBP)
Time Frame: Change from baseline to 0 minutes and 72 hours after the sessions
In the cross-over study (acute effects), the DBP will be assessed through a blood pressure device.
Change from baseline to 0 minutes and 72 hours after the sessions
Heart rate (HR)
Time Frame: Change from baseline to 0 minutes and 72 hours after the sessions
In the cross-over study (acute effects), the HR will be assessed through a blood pressure device.
Change from baseline to 0 minutes and 72 hours after the sessions
Tympanic temperature (TT)
Time Frame: Change from baseline to 0 minutes and 72 hours after the sessions
In the cross-over study (acute effects), the TT will be assessed through a tympanic thermometer.
Change from baseline to 0 minutes and 72 hours after the sessions
Five-repetition sit-to-stand (5STS)
Time Frame: Change from baseline to 0 minutes and 72 hours after the sessions
In the cross-over study (acute effects), the 5STS time will be recorded through a chronometer.
Change from baseline to 0 minutes and 72 hours after the sessions
1-kg Medicine Ball Throw (MBT)
Time Frame: Change from baseline to 0 minutes and 72 hours after the sessions
In the cross-over study (acute effects), the MBT distance will be recorded with a tape measure.
Change from baseline to 0 minutes and 72 hours after the sessions
Inflammatory markers
Time Frame: Change from baseline to week 8
In the eight-week study, inflammatory markers (IL-6, TNF-α, and IL-10) will be analyzed through specific blood testing kits.
Change from baseline to week 8
Oxidative stress
Time Frame: Change from baseline to week 8
In the eight-week study, oxidative stress markers (carbonylated proteins) will be analyzed through specific blood testing kits.
Change from baseline to week 8
Lipid Profile
Time Frame: Change from baseline to week 8
In the eight-week study, the lipid profile (LDL, HDL, total cholesterol, triglycerides) will be analyzed through specific blood testing kits.
Change from baseline to week 8
HbA1c
Time Frame: Change from baseline to week 8
In the eight-week study, the HbA1c will be analyzed through specific blood testing kits.
Change from baseline to week 8
Muscle Damage
Time Frame: Change from baseline to week 8
In the eight-week study, the muscle damage (creatine kinase, lactate dehydrogenase, aspartate aminotransferase, and alanine aminotransferase) will be analyzed through specific blood testing kits.
Change from baseline to week 8
One-repetition maximum (1RM)
Time Frame: Change from baseline to week 8
In the eight-week study, a progressive loading test until reaching the 1RM will be applied in the horizontal leg press and seated chest press machines.
Change from baseline to week 8
Load-velocity profiles
Time Frame: Change from baseline to week 8
In the eight-week study, the load-velocity profiles will be analyzed using the velocity values (recorded with a linear velocity transducer) associated with the absolute loads used during the progressive loading tests in the horizontal leg press and seated chest press machines.
Change from baseline to week 8
Ten-meters walking
Time Frame: Change from baseline to week 8
In the eight-week study, the 10-meter walking time will be measured through a chronometer.
Change from baseline to week 8
1-kg Medicine Ball Throw (MBT)
Time Frame: Change from baseline to week 8
In the eight-week study, the MBT distance will be recorded with a tape measure.
Change from baseline to week 8
Handgrip strength (HGS)
Time Frame: Change from baseline to week 8
In the eight-week study, the HGS will be assessed through an analogic dynamometer.
Change from baseline to week 8
6-Minute Walk Test (6MWT)
Time Frame: Change from baseline to week 8
In the eight-week study, the 6MWT distance will be assessed by multiplying the number of total laps by the lap distance (e.g., 10 laps x 10 meters).
Change from baseline to week 8

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mário C Marques, PhD, University of Beira Interior
  • Principal Investigator: Dulce Esteves, PhD, University of Beira Interior
  • Principal Investigator: Mikel Izquierdo, PhD, Universidad Pública de Navarra

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2023

Primary Completion (Estimated)

April 1, 2024

Study Completion (Estimated)

April 1, 2024

Study Registration Dates

First Submitted

December 14, 2023

First Submitted That Met QC Criteria

December 14, 2023

First Posted (Actual)

December 29, 2023

Study Record Updates

Last Update Posted (Estimated)

January 3, 2024

Last Update Submitted That Met QC Criteria

December 28, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • University of Beira Interior

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild Cognitive Impairment

Clinical Trials on One Resistance Training Set (Single Session)

3
Subscribe